Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study

Abstract

Gastrointestinal Cancers Congress of the European-Society-for-Medical-Oncology (ESMO), Munich, GERMANY, JUN 26-29, 2024